<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05628142</url>
  </required_header>
  <id_info>
    <org_study_id>PTL016</org_study_id>
    <nct_id>NCT05628142</nct_id>
  </id_info>
  <brief_title>Tenon Medical CATAMARAN™ SI Joint Fusion System CT Scan Study</brief_title>
  <official_title>Prospective, Multi-Center, Single Arm Post-Market Study of the Tenon Medical CATAMARAN™ SI Joint Fusion System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tenon Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tenon Medical</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate 6-to-12-month radiographic outcomes of patients&#xD;
      with sacroiliac joint disruptions or degenerative sacroiliitis that have already undergone&#xD;
      treatment with the CATAMARAN SI Joint Fusion System. In addition, retrospective and&#xD;
      prospective clinical outcomes will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with degenerative sacroiliitis or sacroiliac joint disruption who already had the&#xD;
      CATAMARAN Fixation Device implanted between 6 and 12 months will be asked to return for&#xD;
      follow-up visit to evaluate clinical outcomes and undergo a high resolution pelvic CT-Scan to&#xD;
      assess fusion. Additionally, retrospective clinical outcomes will be collected from the&#xD;
      medical records.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 1, 2022</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">November 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiographic Fusion</measure>
    <time_frame>6-12 month post CATAMARAN Fixation Device implantation</time_frame>
    <description>The primary endpoint is the proportion of subjects that demonstrate radiographic fusion assessed by CT-Scan, as evaluated by an Independent Radiologist.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Status</measure>
    <time_frame>6-12 months post-op</time_frame>
    <description>Radiographic assessment for device status: device placement, loosening, migration and/or breakage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical re-intervention for SI joint pain</measure>
    <time_frame>6-12 months post-op</time_frame>
    <description>Proportion of patients requiring surgical re-intervention (removal, revision, reoperation, or supplemental fixation) for SI joint pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic worsening related to the sacral spine</measure>
    <time_frame>6-12 months post-op</time_frame>
    <description>Proportion of patients experiencing neurologic worsening related to the sacral spine compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious device related adverse events</measure>
    <time_frame>6-12 months post-op</time_frame>
    <description>Summary of all serious device related adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sacroiliac Joint Disruption</condition>
  <condition>Degenerative Sacroiliitis</condition>
  <arm_group>
    <arm_group_label>CATAMARAN SI Joint Fusion System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects previously treated with the CATAMARAN Fixation Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Pelvic CT Scan</intervention_name>
    <description>Pelvic CT-Scan between 6-12 months post-op</description>
    <arm_group_label>CATAMARAN SI Joint Fusion System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient &gt;18 years of age at time of treatment with the CATAMARAN SI Joint Fusion&#xD;
             System&#xD;
&#xD;
          -  Patient implanted with the CATAMARAN Fixation Device within the last 12 months&#xD;
&#xD;
          -  Diagnosis of sacroiliac joint disruption or degenerative sacroiliitis&#xD;
&#xD;
          -  Patient, or authorized representative, signs a written Informed Consent form to&#xD;
             participate in the study&#xD;
&#xD;
          -  Patient is willing and able to complete study follow-up requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known or suspected active drug or alcohol abuse&#xD;
&#xD;
          -  Previously diagnosed osteoporosis (defined as prior T-score &lt;-2.5 or history of&#xD;
             osteoporotic fracture) or prior/current use of drug therapy for osteoporosis.&#xD;
&#xD;
          -  Prior fracture of any bone related to cancer/tumor (i.e., pathologic fracture)&#xD;
&#xD;
          -  Prior diagnosis of tumor in sacrum or ilium&#xD;
&#xD;
          -  Unstable fracture of sacrum and or ilium involving the targeted SIJ&#xD;
&#xD;
          -  Osteomalacia or other metabolic bone disease&#xD;
&#xD;
          -  Use of medications known to have detrimental effects on bone quality and soft-tissue&#xD;
             healing&#xD;
&#xD;
          -  Patient is pregnant or wishes to become pregnant during the study period&#xD;
&#xD;
          -  Patient is not likely to comply with the follow-up evaluation schedule&#xD;
&#xD;
          -  Patient is a prisoner or a ward of the state&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Minimally Invasive Neurosurgery of Texas</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George Orthopaedic Spine</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 16, 2022</study_first_submitted>
  <study_first_submitted_qc>November 16, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2022</study_first_posted>
  <last_update_submitted>April 19, 2023</last_update_submitted>
  <last_update_submitted_qc>April 19, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sacroiliitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

